Pharmacyclics commences trial of drug to treat brain metastases
15th Sep 2005, 03:55 GMT
Pharmacyclics has begun enrolling patients in a phase II clinical trial of Xcytrin injection, the company's lead therapeutic candidate for the treatment of brain metastases from solid tumors, or cancer that has spread to the brain.
Latest news from Pharmaceutical Business Review Online:
- Celesio revenues, profits up
- Amgen arthritis drug shows sustained safety and efficacy
- Study supports cardiovascular safety of naproxen
- Cangene chickenpox drug granted orphan status
- Reata brain cancer therapy shows strong activity
- Novartis diabetes drug faces three month delay
- Favrille drug fails secondary goal
- Neurogen commences human testing of obesity drug
- Aeterna prostate cancer drug shows promise
- Isis says new drug effective against cholesterol